Updates on HER2-Directed ADCs Across Solid Tumors : Episode 11
Opinion
Video
Managing ILD and Pneumonitis Risk From ADCs
Vijayakrishna Gadi, MD, PhD, discusses the risk of ILD and pneumonitis from ADCs.
Video content above is prompted by the following:
- What are the most common toxicities associated with ADCs? Which are most concerning for physicians? For patients?
- What toxicities are of greatest concern for patients withgynecologic, GI, Lung ,and GU cancers?
Related Videos
Related Content
